Diabetes Mellitus, Non-Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
221
|
1232
|
0.900 |
None |
0.939 |
9 |
2
|
1993 |
2019 |
Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
205
|
266
|
0.600 |
None |
0.969 |
1 |
|
1995 |
2019 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
108
|
|
0.500 |
None |
1.000 |
1 |
|
2012 |
2013 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
507
|
203
|
0.400 |
None |
1.000 |
2 |
|
1992 |
2019 |
Diabetes Mellitus
|
group |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
32
|
118
|
0.400 |
None |
0.969 |
1 |
|
1995 |
2019 |
Hyperinsulinism
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
28
|
5
|
0.400 |
None |
1.000 |
1 |
|
2000 |
2018 |
Insulin Resistance
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
60
|
53
|
0.400 |
None |
1.000 |
1 |
|
2009 |
2009 |
Coronary Artery Disease
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
65
|
627
|
0.390 |
None |
1.000 |
1 |
|
1999 |
2019 |
Coronary heart disease
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
24
|
469
|
0.370 |
None |
1.000 |
1 |
|
1999 |
2019 |
Coronary Arteriosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
65
|
|
0.370 |
None |
1.000 |
1 |
|
1999 |
2019 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
616
|
281
|
0.350 |
None |
0.600 |
1 |
|
2001 |
2014 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
616
|
1
|
0.320 |
None |
1.000 |
1 |
|
2005 |
2008 |
Precancerous Conditions
|
group |
Neoplasms
|
Neoplastic Process
|
110
|
|
0.300 |
None |
1.000 |
1 |
|
1998 |
1998 |
Neoplastic Cell Transformation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
139
|
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Lipidemias
|
phenotype |
Nutritional and Metabolic Diseases
|
Finding
|
17
|
|
0.300 |
None |
1.000 |
1 |
|
1999 |
1999 |
Compensatory Hyperinsulinemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
26
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Exogenous Hyperinsulinism
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
26
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Endogenous Hyperinsulinism
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
26
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Squamous cell carcinoma of the head and neck
|
disease |
Neoplasms
|
Neoplastic Process
|
52
|
182
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Insulin Sensitivity
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
60
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Hyperlipidemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
17
|
|
0.300 |
None |
1.000 |
1 |
|
1999 |
1999 |
Condition, Preneoplastic
|
disease |
Neoplasms
|
Neoplastic Process
|
110
|
|
0.300 |
None |
1.000 |
1 |
|
1998 |
1998 |
Streptozotocin Diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
108
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Alloxan Diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
108
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |